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Objectives. The present study was designed to evaluate the
effects of an ambulatory training program in patients with chronic
heart failure (CHF) on the ultrastructural morphology of mito-
chondria and fiber type distribution of skeletal muscle and its
relation to peripheral perfusion.
Background. Recent studies in patients with CHF have sug-
gested that intrinsic abnormalities in skeletal muscle can contrib-
ute to the development of early lactic acidosis and fatigue during
exercise.
Methods. Patients were prospectively randomized to either a
training group (n 5 9; mean [6SD] left ventricular ejection
fraction [LVEF] 26 6 10%) participating in an ambulatory
training program or to a physically inactive control group (n 5 9;
LVEF 28 6 10%). At baseline and after 6 months, patients
underwent symptom-limited bicycle exercise testing with measure-
ment of central and peripheral hemodynamic variables as well as
percutaneous needle biopsies of the vastus lateralis muscle. The
mitochondrial ultrastructure of skeletal muscle was analyzed by
ultrastructural morphometry; cytochrome c oxidase activity was
visualized by histochemistry and subsequently quantitated by
morphometry. The fiber type distribution was determined by
adenosine triphosphatase staining.
Results. After 6 months of exercise training there was a
significant increase of 41% in the surface density of cytochrome c
oxidase–positive mitochondria (SVMOcox1) (p < 0.05 vs. con-
trol) and of 43% in the surface density of mitochondrial cristae
(SVMC) (p < 0.05 vs. control). Furthermore, exercise training
induced a 92% increase in the surface density of the mitochondrial
inner border membrane (p < 0.05 vs. control). In contrast, the
total number of cytochrome c oxidase–positive mitochondria
remained essentially unchanged. Exercise-induced improve-
ment in peak oxygen uptake was closely linked to changes in
SVMOcox1 (p < 0.01, r 5 0.66). After exercise training, changes
in submaximal femoral venous lactate levels were not related to
changes in submaximal leg blood flow (r 5 20.4), but were
inversely related to changes in the volume density of mitochondria
(p 5 0.01; r 5 20.6) as well as to changes in SVMC (p < 0.05; r 5
20.5). After exercise training there was a “reshift” from type II to
type I fibers (p < 0.05 vs. control).
Conclusions. Patients with CHF who engage in regular physical
exercise show enhanced oxidative enzyme activity in the working
skeletal muscle and a concomitant reshift to type I fibers. These
exercise-induced changes in oxidative capacity appear to be
unrelated to changes in peripheral perfusion.
(J Am Coll Cardiol 1997;29:1067–73)
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It has been well established that alterations in peripheral
hemodynamic variables and intrinsic abnormalities in skeletal
muscle structure and metabolism in patients with chronic heart
failure (CHF) are responsible for the early onset of anaerobic
metabolism during exercise, which contributes substantially to
their reduced exercise capacity (1–5). Major alterations in
skeletal muscle ultrastructure and biochemistry have been
demonstrated in patients with CHF, including fiber atrophy,
transformation of slow-twitch type I to fast-twitch type II fibers
and a decrease in oxidative enzyme capacity.
Recently published studies in our laboratory (6) and others
(1,2,5,7–10) have focused on the effect of exercise training on
central and peripheral hemodynamic data as well as on skeletal
muscle structure and metabolism. We demonstrated that reg-
ular physical exercise increases maximal exercise tolerance and
delays anaerobic metabolism during submaximal exercise in
patients with CHF. Improved aerobic exercise capacity was
closely linked to an exercise-induced increase in oxidative
capacity of the working skeletal muscle.
In the present study, we sought to investigate in the same
patient group the effects of regular physical exercise on the
ultrastructure of mitochondria (i.e., surface density of mito-
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chondrial cristae and inner border membrane) and muscle
fiber distribution in skeletal muscle. In addition, we intended
to examine the relation between exercise-induced changes in
peripheral hemodynamic data and the oxidative capacity of
mitochondria in skeletal muscle.
Methods
The patient group, exercise training methods and proce-
dures for incremental bicycle exercise testing were described
previously (6). In brief, 22 patients were initially enrolled in the
study; three patients from the training group and one patient
from the control group did not complete the study and were
excluded from analysis. One patient from each group refused
follow-up examinations. One patient from the training group
had to be excluded because of atrioventricular node reentrant
tachycardia, and another patient from the training group died
suddenly, unrelated to exercise. The remaining 18 patients
(nine patients from the training group and nine patients from
the control group) who completed the study were included in
the analysis. The central and peripheral hemodynamic changes
in response to long-term exercise were reported previously (6).
Patient selection. Male patients with clinical, radiologic
and echocardiographic signs of CHF (New York Heart Asso-
ciation functional class II–III) as a result of dilated cardiomy-
opathy or ischemic heart disease were asked to participate in
this study. Inclusion criteria were reduced left ventricular
ejection fraction (LVEF ,40%), as assessed by radionuclide
scintigraphy, or a restricted fractional shortening ,30% by
echocardiography, willingness to participate in the study for at
least 6 months and permanent residence within 25 km of the
training facilities. Physical work capacity at baseline had to be
.25 W without signs of myocardial ischemia, i.e., angina
pectoris or ST segment depression. Patients with exercise-
induced myocardial ischemia, ventricular tachyarrhythmias
(.Lown 4a), significant valvular heart disease, uncontrolled
hypertension, peripheral vascular disease, chronic obstructive
pulmonary disease and orthopedic or other conditions preclud-
ing regular participation in exercise sessions were excluded
from the study.
Study protocol. Written informed consent was obtained
from all patients before they entered the study, which was
approved by the Local Ethics Committee. Patients had to be
clinically stable for at least 3 months before entry into the
study. Before baseline measurements, all patients underwent a
maximal exercise test and participated in one group training
session with 24-h Holter monitoring to get acquainted with the
examinations and to detect exercise-induced ventricular tachy-
arrhythmias.
At baseline and after 6 months, percutaneous needle biop-
sies of the vastus lateralis muscle were obtained. Two days
after exercise testing, patients were instrumented with a 5F
thermodilution Swan-Ganz catheter, which was positioned in
the right femoral vein as described by Sullivan et al. (10), and
with a 7F Swan-Ganz catheter, which was introduced into the
right pulmonary artery. Hemodynamic and gas exchange mea-
surements as well as blood samples for determination of
oxygen saturation and femoral venous lactate levels were
simultaneously obtained at rest and at the end of each work
load during bicycle exercise. Exercise testing was performed on
a calibrated, electronically braked bicycle in an upright posi-
tion. Work load was increased progressively every 3 min in
steps of 25 W until exhaustion. Exercise testing was repeated
after 6 months.
After baseline measurements patients were randomized to
either a training group or to an inactive control group. Patients
assigned to the training program stayed on an intermediate
care ward for the initial 3 weeks of the training program.
Patients exercised six times daily for 10 min on a bicycle
ergometer under close supervision. They were instructed to
warm up before each training session at 25 W for 1 min and
then to increase the resistance setting until the heart rate was
70% of the previously determined maximum. On discharge
from the hospital patients were lent a bicycle ergometer for use
at home. They were asked to exercise close to their target heart
rate twice daily for a minimum of 40 min altogether. In
addition, they were expected to participate in at least two
group training sessions of 60 min each per week. Exercise
sessions consisted of walking, calisthenics and ball games. An
electrocardiography-based pulse-rate monitor was used during
exercise outside the hospital to minimize the risk of exercise-
induced arrhythmia. Patients assigned to the control group
received their individually tailored cardiac medication and
were supervised by their private physicians.
Respiratory gas exchange variables. Patients breathed air
through a mouthpiece with a nose clip in place, and continuous
on-line ventilation and expiratory gas data were collected using
a commercially available system (Jaeger EOS-Sprint). Venti-
latory threshold (Vt) was defined as the oxygen uptake before
the systematic increase in the ventilatory equivalent for oxygen
(VE/VO2) without a concomitant increase in the ventilatory
equivalent for carbon dioxide (VE/VCO2) (11). Ventilatory
threshold was evaluated by two independent observers who
had no knowledge of the patients’ identity and the sequence of
exercise tests performed.
Abbreviations and Acronyms
ATPase 5 adenosine triphosphatase
CHF 5 chronic heart failure
LVEF 5 left ventricular ejection fraction
SVMIBM 5 surface density of mitochondrial inner border
membrane
SVMC 5 surface density of mitochondrial cristae
SVMO 5 surface density of mitochondria
SVMOcox1 5 surface density of cytochrome c oxidase–positive
mitochondria
Vt 5 ventilatory threshold
VVM 5 volume density of mitochondria
VVMcox1 5 volume density of cytochrome c oxidase–positive
mitochondria
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Muscle biopsy. At baseline and after 6 months, percutane-
ous needle biopsies from the middle part of the vastus lateralis
muscle were obtained under local anesthesia as described by
Bergstro¨m (12). The specimens were examined using an EM
200 Philips electron microscope. Each biopsy was cut into four
blocks and 15 microphotographs were randomly taken from
each block. The samples were photographed at a primary
magnification of 315,500 and analyzed at a final magnification
of 360,000 with the aid of a 1,089-point and 121-testline
multipurpose test grid superimposed over each microphoto-
graph. The following mitochondrial structures were analyzed:
volume density of mitochondria (VVM), surface density of
mitochondria (SVMO), surface density of mitochondrial inner
border membrane (SVMIBM) and surface density of mitochon-
drial cristae (SVMC), that is, VVM 5 counted points/total
points of grid, and SVM 5 intersections per test line/total
length of test line of grid, as reported previously (1,13). Using
standard stereologic principles of electron microscopy, we
obtained the VVM (i.e., mitochondrial volume fraction per
unit volume muscle tissue, expressed as percent volume), the
SVMO (i.e., surface fraction of mitochondria per unit volume
of muscle, expressed as square meters per cubic centimeters),
the SVMIBM (i.e., surface fraction of mitochondrial inner
border membrane per unit volume of muscle, expressed as
square meters per cubic centimeters) and the SVMC (i.e.,
surface fraction of mitochondrial cristae per unit volume of
muscle, expressed as square meters per cubic centimeters).
Histochemistry of cytochrome c oxidase in mitochondria. In
all patients, the diaminobenzidine cytochrome oxidase reaction
was performed in mitochondria as described elsewhere (1),
using a modification of the technique reported by Perotti et al.
(14), to provide a reliable criterion of the mitochondrial
cytochrome oxidase activity in skeletal muscle. From each
patient 60 microphotographs were analyzed to determine
the VVM and SVMO as described above. The mitochondria
were classified as cytochrome oxidase–positive when diami-
nobenzidine staining was visible within the mitochondria.
Diaminobenzidine-negative mitochondria may reflect a low
cytochrome oxidase activity. All specimens for ultrastructural
morphometry were coded and analyzed by an independent
technician who was unaware of clinical data or group assign-
ment.
The first 10 biopsies were analyzed independently by two
investigators. The interobserver variability was r 5 0.95 for the
determination of VVM (p , 0.0001) and r 5 0.91 for the
determination of SVMC (p , 0.001).
Determination of fiber types. One part of the skeletal
muscle tissue was immediately frozen in liquid nitrogen for
analysis of fiber types (slow-twitch type I and fast-twitch type
II), which were determined by the myofibrillar adenosine
triphosphatase (ATPase) staining technique resulting from
preincubation at pH 9.4 (15). This method distinguishes type I
(light staining) fibers from type II (dark staining) fibers. From
each muscle biopsy, we randomly cut four blocks and also
randomly took five samples from each block. After preincuba-
tion the samples were photographed at a final magnification of
3100. Determination of each muscle fiber type were visually
conducted as described elsewhere (1). Approximately 50 fibers
were contained on each photograph. This method of determin-
ing the percentage of a given fiber type within a muscle biopsy
was reproducible to within ,5% (16).
Statistical analysis. The mean value 6 SD was calculated
for all variables. For statistical evaluation nonparametric tests
(Mann-Whitney U test, Wilcoxon signed rank test) were used
to avoid potential errors from non-normal distribution of data.
Linear regression analysis was used to determine the relation
of changes of hemodynamic and morphologic variables to
change in maximal oxygen uptake. A p value ,0.05 was
considered statistically significant.
Results
Study group (Table 1). Nine patients with CHF due to left
ventricular dysfunction (LVEF 26 6 10%) completed a period
of 6 months of aerobic exercise conditioning. At baseline,
patients in the control group (n 5 9) did not differ significantly
from those in the training group (n 5 9) with respect to age,
etiology of heart failure, LVEF and left ventricular end-
diastolic diameter or functional class. All patients completing
the study were taking angiotensin-converting enzyme inhibi-
tors. Eighty-seven percent of the patients were on diuretics and
82% were on digoxin. Drug treatment was comparable in both
groups and was not changed in any subject completing the trial
during the last 4 weeks before the study or during the study
course.
Mitochondrial ultrastructure of skeletal muscle (Table 2).
Training group. Comparable to the recently reported exercise-
induced increase of volume density of cytochrome c oxidase–
positive mitochondria (VVMcox1) by 41% (p , 0.05 vs.
control) (6), surface density of cytochrome c oxidase–positive
mitochondria (SVMOcox1) increased significantly by 41%
(p , 0.05 vs. control), whereas SVMOcox2 remained un-
changed (p 5 0.5) after 6 months of physical exercise. Surface
density of cox1 mitochondrial cristae increased by 43% (p ,
0.05 vs. control) to the same extent as SVMOcox1 and







Age (yr) 50 6 12 52 6 8
Etiology of heart failure
Dilated cardiomyopathy 9 8
Ischemic heart disease 0 1
LVEF (%) 26 6 10 28 6 10




*Data are presented as mean value 6 SD or number of patients. LVDD 5
left ventricular diastolic dimension assessed by echocardiography; LVEF 5 left
venticular ejection fraction; NYHA 5 New York Heart Association.
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VVMcox1. As a consequence, there were no changes in the
relations between SVMC and SVMOcox1 (1.34 6 0.32 vs.
1.42 6 0.26; p 5 0.38) as well as SVMC and VVMcox1
(0.14 6 0.04 vs. 0.15 6 0.03; p 5 0.6) after the training period.
Surface density of mitochondrial inner border membrane,
however, increased after exercise training by 92% (p , 0.05 vs.
control), resulting in a significant increase in the relations
between SVMIBM and SVMOcox1 (0.18 6 0.12 to 0.27 6
0.12; p , 0.05 vs. control) and SVMIBM and VVMcox1
(0.02 6 0.01 to 0.03 6 0.01; p , 0.05 vs. control). The total
number of cytochrome oxidase–positive mitochondria did not
change significantly after training (p 5 0.18), but the mean
surface density of a single cytochrome c oxidase–positive
mitochondrium increased by 31% (p , 0.05 vs. control).
Control group. With regard to the surface density of mito-
chondria, mitochondrial cristae or mitochondrial inner border
membrane, there was no significant change after 6 months.
Skeletal muscle fiber types (Table 3, Fig. 1). At the begin-
ning of the study the percentage of slow-twitch type I fibers was
not different between the groups. The percentage of slow-
twitch type I fibers in patients of both groups averaged 48 6
6% (type II, 52%) compared with 55 6 14% (type II, 45%) in
normal patients (1). After 6 months of exercise training, a
significant 8% increase in type I fibers (p , 0.05 vs. control)
was observed, whereas type II fibers decreased significantly
(p , 0.05 vs. control) in these patients. In the control group, a
6% decrease of type I fibers (p , 0.05 vs. begin) was detected,
and type II fibers tended to increase after 6 months (p 5 0.1).
Relation between changes in femoral venous lactate levels
and changes in leg blood flow. To assess the relation of
hemodynamic data and skeletal muscle factors in determining
the delayed onset of anaerobic metabolism after exercise
training, we performed linear regression analysis of changes in
femoral venous lactate at submaximal exercise with changes in
skeletal muscle ultrastructure and leg blood flow at the corre-
sponding work rate. At the beginning there was no significant
correlation between femoral venous lactate levels and leg
blood flow during submaximal exercise (r 5 20.33, p 5 0.22).
After exercise training changes in femoral venous lactate
during submaximal exercise were furthermore unrelated to
changes in submaximal leg blood flow (r 5 20.36, p 5 0.2), but
were inversely correlated with changes in volume density of
mitochondria (r 5 20.58, p 5 0.01) and with changes in
SVMC (r 5 20.48, p , 0.05) (Fig. 2).
Correlation between functional capacity and skeletal mus-
cle morphology. After 6 months of physical exercise, changes
in peak oxygen uptake was significantly related to changes in
SVMOcox1 (r 5 0.66, p , 0.01), SVMIBM (r 5 0.6, p , 0.01)
and SVMC (r 5 0.58, p , 0.01). No correlation was found
between the surface density of cytochrome oxidase–positive
mitochondria at the beginning of the study or the change in
surface density of cytochrome oxidase–positive mitochondria
and patient age, duration of heart failure or functional class.
Table 2. Ultrastructural Changes in Skeletal Muscle After Exercise Training
Variable Baseline 6 Months Change (%)
Training
SVMOcox1 (m
2/cm3) 0.24 6 0.12 0.33 6 0.10*† 0.09 6 0.09 (41%)†
SVMOcox2 (m
2/cm3) 0.37 6 0.09 0.31 6 0.06 20.06 6 0.08 (215%)
SVMIBM (m
2/cm3) 0.05 6 0.05 0.10 6 0.06*† 0.05 6 0.04 (92%)†
SVMC (m2/cm3) 0.34 6 0.21 0.48 6 0.20*† 0.14 6 0.14 (43%)†
Ncox1 (n) 4.3 6 2.0 5.1 6 1.8 0.8 6 1.1 (19%)
Ncox2 (n) 9.4 6 2.3 8.2 6 2.0 21.2 6 2.8 (213%)
SVMOcox1/NSVMOcox1 (m
2/cm3) 0.005 6 0.001 0.007 6 0.001*† 0.002 6 0.001 (21%)†
Control
SVMOcox1 (m
2/cm3) 0.22 6 0.12 0.17 6 0.10 20.05 6 0.08 (223%)
SVMOcox2 (m
2/cm3) 0.36 6 0.08 0.36 6 0.06 0 6 0.09 (60%)
SVMIBM (m
2/cm3) 0.04 6 0.04 0.04 6 0.03 0 6 0.02 (60%)
SVMC (m2/cm3) 0.32 6 0.22 0.29 6 0.18 20.03 6 0.10 (210%)
Ncox1 (n) 3.9 6 2.2 3.4 6 1.8 20.5 6 1.5 (213%)
Ncox2 (n) 9.4 6 1.5 9.8 6 1.4 0.4 6 2.2 (4%)
SVMOcox1/NSVMOcox1 (m
2/cm3) 0.006 6 0.002 0.006 6 0.003 0 6 0.003 (60%)
Significantly different from baseline: *p , 0.05. Significantly different from control: †p , 0.05. Data are presented as
mean value 6 SD. SVMOcox1(cox2) 5 surface density of cytochrome c oxidase–positive (negative) mitochondria;
SVMIBM 5 surface density of mitochondrial inner border membrane; SVMC 5 surface density of mitochondrial cristae;
Ncox1 (cox2) 5 mean number of cytochrome c oxidase–positive (negative) mitochondria per micrograph; SVMOcox1/
NSVMOcox1 5 mean surface density of a single cytochrome c oxidase–positive mitochondrium.
Table 3. Muscle Fiber Distribution
Variable Baseline 6 Months Change (%)
Training
Fiber type I (%) 48 6 7 52 6 7* 4 6 4 (8%)†
Fiber type II (%) 52 6 7 48 6 6* 4 6 5 (28%)†
Control
Fiber type I (%) 49 6 5 46 6 7* 23 6 5 (26%)
Fiber type II (%) 51 6 5 54 6 10 3 6 6 (6%)
Significantly different from baseline: *p , 0.05. Significantly different from
control: †p , 0.05. Data are presented as mean value 6 SD.
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Changes in percentage of fibers being classified as slow-
twitch type I fibers were significantly correlated with changes in
total volume density of mitochondria (r 5 0.48, p , 0.05), as
well as with volume density of cytochrome c oxidase–positive
mitochondria (r 5 0.52, p , 0.05) (Fig. 3). Furthermore,
changes in percentage in type I fibers were also significantly
correlated with both changes in oxygen uptake at the Vt (p ,
0.01, r 5 0.57) and peak oxygen uptake (p , 0.01, r 5 0.62).
Discussion
The two salient findings derived from this study are 1)
aerobic endurance training induces correction of ultrastruc-
tural abnormalities and muscle fiber distribution in skeletal
muscle in patients with CHF; and 2) the increase of aerobic
functional capacity is closely linked to changes in mitochon-
drial ultrastructure but unrelated to changes in peripheral
perfusion. The results of this study highlight the part of skeletal
muscle alterations played in the genesis of exercise intolerance
in CHF and indicate that persistent regular exercise may at
least in part correct some of these changes.
Training effects on mitochondrial ultrastructure. Exercise
intolerance and fatigue are hallmarks of CHF, but paradoxi-
cally their severity correlates poorly with central hemodynamic
variables (17–20). This discrepancy is in part explained by
compromised peripheral blood flow, but sufficient evidence has
been gleaned from previous studies to suggest a central role of
skeletal muscle (5,21–25). These findings include alterations in
oxidative metabolism of the skeletal muscle in patients with
CHF by ultrastructural, cytochemical and biochemical analysis
as well as by nuclear magnetic resonance spectroscopy
(1,5,16,26–28). Furthermore, it has been shown that changes in
oxidative capacity of skeletal muscles are correlated with
Figure 1. Microphotograph of myofibrillar ATPase stain at pH 9.4 for
a normal subject (A) and a patient from the control group (B).
Black-stained fibers are type II and light fibers are type I. In the
patient with CHF a shift to an increased percentage of type II fibers
compared with the normal subject is apparent.
Figure 2. Changes in submaximal femoral ve-
nous lactate level (dLac) correlated with
changes in submaximal leg blood flow (dLBF)
(right); changes in submaximal femoral venous
lactate level (dLac) correlated with changes in
volume density of mitochondria (dVVM)
(left). Circles 5 patients from the training
group; triangles 5 patients from the control
group.
Figure 3. Changes in volume density of cytochrome c oxidase–positive
mitochondria (dVVMcox1) correlated with changes in muscle fiber
type I (dType I). Circles 5 patients from the training group; trian-
gles 5 patients from the control group.
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changes in exercise capacity (1). In a recently published study
(6), we were able to show that in patients with CHF, the
volume density of cytochrome c oxidase–positive mitochondria
could be increased by regular physical exercise. Improvement
of functional status was closely linked to changes in oxidative
capacity of skeletal muscle. The present study sought to
determine the ultrastructural changes of mitochondria in the
same patient group. Initially, the surface density of cytochrome
c oxidase–positive mitochondria was reduced by 45% com-
pared with normal subjects, thereby compromising the oxida-
tive capacity of working skeletal muscle (1). The origin of these
changes awaits definition, although several mechanisms have
been implicated, such as deconditioning and expression of the
inducible form of nitric oxide synthase (1,29,30). This enzyme
could be located by immunohistochemical analysis in skeletal
muscle myocytes of patients with CHF in our laboratory
(unpublished data). The large amounts of nitric oxide pro-
duced by nitric oxide synthase is likely to interfere with
numerous cellular functions and properties, such as key en-
zymes of the mitochondrial respiratory chain (31). The results
of this study indicate that some of these untoward changes can
be ameliorated by regular physical exercise: surface density of
mitochondrial inner border membrane increased by 92% and
surface density of mitochondrial cristae by 41%. Interestingly,
the exercise-induced increase in inner border membranes
appears more pronounced than the increase in mitochondrial
cristae, suggesting a higher increase in the activity of cyto-
chrome c oxidase, a rate limiting enzyme, at the inner border
membranes of mitochondria compared with mitochondrial
cristae in skeletal muscle cells.
Training effects on muscle fiber distribution. Skeletal mus-
cle abnormalities represent an inherent feature of CHF. These
include a shift in fiber type distribution with a significant
increase in the proportion of type II fibers and a reduced
activity of cytochrome c oxidase (1). Fast-twitch fibers (type II)
have a low aerobic potential and therefore are easily fatigued.
An increase in the percentage of such fibers might be expected
to reduce muscle performance during strenuous exercise;
slowly contracting, high endurance motor units are primarily
recruited during low level exercise (16). In the present study a
“reshift” from fast-twitch type II fibers to slow-twitch type I
fibers was observed in patients of the training group. These
changes were linked to an improvement in functional capacity.
Individual muscle fibers are classified by ATPase staining
techniques according to their content of oxidative capacity;
fibers falling below a certain critical level are classified as type
II, fibers falling above this level as type I. Thus, an overall loss
of oxidative capacity, as observed in CHF, may effect fiber type
distribution in skeletal muscle by a shift toward type II fibers
(1). In this study physical exercise was shown to enhance
oxidative capacity across both muscle fiber types and therefore
to reverse this trend. In other words, the pattern of fiber types
observed at baseline and after exercise therapy reflects overall
changes in oxidative capacity.
Metabolic and peripheral hemodynamic variables. In the
present study changes in femoral venous lactate accumulation
at submaximal exercise are inversely related to changes in
aerobic enzyme capacity of skeletal muscle. This finding is
consistent with previous studies that identified aerobic enzyme
content as an important determinant of lactate production
during exercise in humans (32,33) and animals (32,34). Short-
term improvements of central hemodynamic data, elicited by
administration of inotropic agents, fail to increase peripheral
oxygen utilization within the working muscle (35–37), whereas
long-term vasodilator therapy may result in correction of peak
oxygen uptake after a period of months (35,37). Similarly,
skeletal muscle function remains abnormal for up to a year,
even after successful heart transplantation associated with
nearly instantaneous normalization of central hemodynamic
data (38). The previous uncontrolled study by Sullivan et al.
(10) has shown that exercise training in this disorder decreases
blood lactate levels during submaximal exercise and improves
functional capacity without improving cardiac output or leg
blood flow during submaximal exercise. In the present study we
found an inverse correlation between changes in femoral
venous lactate accumulation during exercise and changes in
oxidative capacity of skeletal muscle after the training period,
but no link to changes in submaximal leg blood flow, suggesting
that increases in aerobic enzyme activity in skeletal muscle may
play an important role in improving exercise tolerance after
training. It is noteworthy that the absent correlation between
leg blood flow and femoral venous lactate levels does not
necessarily indicate that decreased leg blood flow does not
contribute to early anaerobic metabolism in this disorder.
However, other factors are likely to be involved in local
muscular exercise intolerance of patients with CHF. Such
factors may include failure of excitation-contraction coupling
(39), inefficiency of chemical to mechanical energy transduc-
tion or reflex inhibition of motor unit activation (27). Piepoli et
al. (40) demonstrated in a recently published study that
physical training not only improves the exercise capacity of the
trained forearm but also partially reverses the abnormal re-
sponses to exercise through a reduction of the activity of the
muscle ergoreflex, either directly or through a reduction of the
metabolic signal activating the ergoreceptors. Moreover, CHF
is associated with endothelial dysfunction, including impaired
endothelium-mediated, flow-dependent dilation. In animal
models endothelial function could be partially restored by
exercise (41,42), and most recently, Hornig et al. (43) were able
to demonstrate that physical exercise restores endothelium-
mediated, flow-dependent dilation of the radial artery in
patients with CHF after 4 weeks of daily handgrip training,
possibly by enhanced endothelial synthesis and release of nitric
oxide.
Clinical implications. The results of the present study
show that regular physical exercise in patients with CHF
induced an improvement in exercise tolerance associated with
a reduction in ultrastructural abnormalities of skeletal muscle.
Changes in anaerobic metabolism assessed by femoral venous
lactate accumulation during submaximal exercise were in-
versely related to changes in oxidative capacity of skeletal
muscle, but unrelated to changes in peripheral perfusion.
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Endurance training, carefully and individually tailored to the
patient’s requirements, seems to be an additional therapeutical
option to prevent the deleterious effects of deconditioning in
stable patients with CHF.
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